CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigate Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
13,421 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0405

Mazdutide

Filed under Peptides. The bureau holds 72 laboratory returns for this compound from 17 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

17 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
Tianjin Finder Chemical TFCCASE #VI-2026-0693A710.09.910.014 Nov 202516 Apr 2026
HomopeptideCASE #VI-2026-0760A69.99.910.025 May 202625 May 2026
Qingdao Sigma Chemical QSCCASE #VI-2026-0538A88.78.110.023 May 202623 May 2026
UtherCASE #VI-2026-0902A28.58.18.99 Oct 20259 Oct 2025
Shanghai Sigma Audley SSACASE #VI-2026-0486A88.47.39.525 May 202625 May 2026
Glbiochem (Shanghai)CASE #VI-2026-0704A48.37.69.021 May 202621 May 2026
Planet PeptideCASE #VI-2026-0092A38.27.88.725 Apr 20256 May 2025
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594A88.17.19.424 May 202624 May 2026
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284A57.96.210.024 May 202624 May 2026
Peptide-SCASE #VI-2026-0111A47.97.19.216 Jul 202525 Nov 2025
Skye PeptidesCASE #VI-2026-0451A57.77.18.26 May 202516 Aug 2025
Nuscience PeptidesCASE #VI-2026-0554B26.96.97.06 May 20256 May 2025
LN PeptidesCASE #VI-2026-0781X16.86.86.89 Oct 20259 Oct 2025
Polaris PeptidesCASE #VI-2026-0839B36.15.76.530 Apr 20256 May 2025
Elite Research USACASE #VI-2026-0267C35.34.16.027 Jun 202525 Nov 2025
TydesCASE #VI-2026-0493C35.04.75.425 Apr 202530 Apr 2025
Pharma Grade PeptidesCASE #VI-2026-0208E24.03.94.06 May 20256 May 2025

Open any subject to view the batch-level evidence for Mazdutide alone.